SCHEMBL7415538

SCHEMBL7415538

N#CC1(N(Cc2ccccc2)C(=O)[CH]Cc2ccc(Cl)cc2C(N)=O)CCNC1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 5/20 0.32
JAK2 O60674 1/20 0.32
JAK1 P23458 1/20 0.32
SLC6A2 P23975 2/20 0.31
SLC6A4 P31645 2/20 0.31
CYP2D6 P10635 1/20 0.31
SLC6A3 Q01959 1/20 0.31
KDM4E B2RXH2 3/20 0.31
ALDH1A1 P00352 3/20 0.31
NPC1 O15118 1/20 0.31
MAPT P10636 1/20 0.31
PKM P14618 1/20 0.31
HPGD P15428 1/20 0.31
NFKB1 P19838 1/20 0.31
HTT P42858 1/20 0.31
RAB9A P51151 1/20 0.31
NFKB2 Q00653 1/20 0.31
RELA Q04206 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
SNCA P37840 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7021618 0.78 SNCA (0.34) SLC6A2SLC6A4CYP2D6SLC6A3HPGD
SCHEMBL7420191 0.78 SNCA (0.34) SLC6A2SLC6A4CYP2D6SLC6A3SNCA
SCHEMBL7415546 0.74 PSEN1 (0.34) CYP2D6KDM4EALDH1A1CTSSCTSK
SCHEMBL7416904 0.72 SNCA (0.35) CYP2D6SNCATMEM97SIGMAR1CTSS
SCHEMBL7420196 0.70 CTSS (0.36) SLC6A2SLC6A4CYP2D6SLC6A3NPC1
SCHEMBL7021621 0.70 RXFP1 (0.34) SLC6A2SLC6A4CYP2D6SLC6A3SNCA
SCHEMBL7418232 0.69 PTGES (0.35)
SCHEMBL7420829 0.69 SNCA (0.34) ALDH1A1SNCACTSSCTSK
SCHEMBL7422302 0.68 SLC6A2 (0.35) SLC6A2SLC6A4SLC6A3
SCHEMBL7414438 0.68 PTGES (0.36) KDM4EALDH1A1PKMHPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP disclosed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO disclosed